Aprea Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Aprea Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Corporate Presentation

Aug 12, 2025

Slides

Q2 2025

Aug 12, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 14, 2025

Earnings release8-K

Quarterly report10-Q

Corporate Presentation

May 14, 2025

Slides

2024

Q4 2024

Mar 25, 2025

Annual report10-K

Earnings release8-K

Slides

Corporate Presentation

Nov 7, 2024

Slides

Q3 2024

Nov 7, 2024

Earnings release8-K

Q2 2024

Aug 12, 2024

Earnings release8-K

Quarterly report10-Q

Study Update

Jun 24, 2024

Slides

Q1 2024

May 14, 2024

Earnings release8-K

Quarterly report10-Q

2023

Q4 2023

Mar 26, 2024

Earnings release8-K

Q3 2023

Nov 9, 2023

Earnings release8-K

Quarterly report10-Q

Study Update

Oct 31, 2023

Slides

Q2 2023

Aug 10, 2023

Earnings release8-K

Q1 2023

May 15, 2023

Earnings release8-K

2022

Q4 2022

Mar 30, 2023

Earnings release8-K

Q3 2022

Nov 9, 2022

Earnings release8-K

Q2 2022

Aug 12, 2022

Earnings release8-K

Quarterly report10-Q

Q1 2022

May 16, 2022

Earnings release8-K

Quarterly report10-Q

2021

Q4 2021

Mar 15, 2022

Earnings release8-K

Q3 2021

Nov 8, 2021

Earnings release8-K

Quarterly report10-Q

Q2 2021

Aug 12, 2021

Earnings release8-K

Quarterly report10-Q

Q1 2021

May 6, 2021

Earnings release8-K